786 related articles for article (PubMed ID: 15845886)
21. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
22. [Pulmonary arterial hypertension and BMP system abnormality].
Otsuka F
Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension.
Dewachter L; Adnot S; Guignabert C; Tu L; Marcos E; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Eddahibi S
Eur Respir J; 2009 Nov; 34(5):1100-10. PubMed ID: 19324947
[TBL] [Abstract][Full Text] [Related]
24. [Effects of injuries pulmonary arterial endothelial cell induced by endotoxin on proliferation of pulmonary artery smooth muscle cells and interference effect of bone morphogenetic protein-2].
Pei L; Shan SM; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):40-5. PubMed ID: 18346379
[TBL] [Abstract][Full Text] [Related]
25. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
27. Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.
Fantozzi I; Huang W; Zhang J; Zhang S; Platoshyn O; Remillard CV; Thistlethwaite PA; Yuan JX
Exp Lung Res; 2005 Oct; 31(8):783-806. PubMed ID: 16368652
[TBL] [Abstract][Full Text] [Related]
28. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells.
Liu Y; Ren W; Warburton R; Toksoz D; Fanburg BL
FASEB J; 2009 Jul; 23(7):2299-306. PubMed ID: 19244313
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.
Pouliot F; Blais A; Labrie C
Cancer Res; 2003 Jan; 63(2):277-81. PubMed ID: 12543773
[TBL] [Abstract][Full Text] [Related]
30. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.
Ihida-Stansbury K; McKean DM; Lane KB; Loyd JE; Wheeler LA; Morrell NW; Jones PL
Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L694-702. PubMed ID: 16782755
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1 alters BMP signaling to promote proliferation of pulmonary artery smooth muscle cells.
Maruyama H; Sakai S; Ieda M
Can J Physiol Pharmacol; 2022 Oct; 100(10):1018-1027. PubMed ID: 36037530
[TBL] [Abstract][Full Text] [Related]
32. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
Morty RE; Nejman B; Kwapiszewska G; Hecker M; Zakrzewicz A; Kouri FM; Peters DM; Dumitrascu R; Seeger W; Knaus P; Schermuly RT; Eickelberg O
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1072-8. PubMed ID: 17347486
[TBL] [Abstract][Full Text] [Related]
33. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters.
Liu Y; Tian HY; Yan XL; Fan FL; Wang WP; Han JL; Zhang JB; Ma Q; Meng Y; Wei F
Cardiovasc Pathol; 2013; 22(6):451-7. PubMed ID: 23601559
[TBL] [Abstract][Full Text] [Related]
34. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
35. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension.
Rudarakanchana N; Flanagan JA; Chen H; Upton PD; Machado R; Patel D; Trembath RC; Morrell NW
Hum Mol Genet; 2002 Jun; 11(13):1517-25. PubMed ID: 12045205
[TBL] [Abstract][Full Text] [Related]
37. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
Han X; Chen C; Cheng G; Liang L; Yao X; Yang G; You P; Shou X
Microvasc Res; 2015 Jul; 100():17-24. PubMed ID: 25937083
[TBL] [Abstract][Full Text] [Related]
39. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
[TBL] [Abstract][Full Text] [Related]
40. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH.
Nasim MT; Ogo T; Chowdhury HM; Zhao L; Chen CN; Rhodes C; Trembath RC
Hum Mol Genet; 2012 Jun; 21(11):2548-58. PubMed ID: 22388934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
